Neogenomics Inc (NEO)

08:22 AM

Liquid Biopsy Market to Reach US$28.20 Billion by 2033 at 12.8% - openPR.com

08:22 AM

Mar 12, 2026

Trend Review: Can NeoGenomics Inc keep up with sector leadersQuarterly Trade Summary & Weekly Return Optimization Alerts - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

NeoGenomics (NASDAQ:NEO) Stock Price Down 7.9%Should You Sell? - MarketBeat

Mar 12, 2026

Mar 12, 2026

Greenhouse Funds LLLP Acquires 789,510 Shares of NeoGenomics, Inc. $NEO - MarketBeat

Mar 12, 2026

Mar 10, 2026

NeoGenomics at Leerink Conference: Strategic Growth Focus - Investing.com

Mar 10, 2026

Mar 08, 2026

Investment Recap: Is NeoGenomics Inc gaining market share2026 Volatility Report & Long Hold Capital Preservation Tips - baoquankhu1.vn

Mar 08, 2026

Mar 07, 2026

Insider Sell: Can NeoGenomics Inc deliver alphaMarket Activity Report & Expert Verified Movement Alerts - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

GW&K Investment Management LLC Cuts Stock Position in NeoGenomics, Inc. $NEO - MarketBeat

Mar 07, 2026

Mar 07, 2026

Royce & Associates LP Sells 860,000 Shares of NeoGenomics, Inc. $NEO - MarketBeat

Mar 07, 2026

Mar 05, 2026

Vanguard Group Inc. Has $107.34 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat

Mar 05, 2026

Mar 04, 2026

NeoGenomics, Inc. $NEO Shares Sold by Segall Bryant & Hamill LLC - MarketBeat

Mar 04, 2026

Mar 03, 2026

NeoGenomics (NEO) accounting chief granted new options and RSUs - Stock Titan

Mar 03, 2026

Mar 03, 2026

Equity awards expand NeoGenomics (NEO) EVP Olivo’s stock-based pay - Stock Titan

Mar 03, 2026

Mar 03, 2026

NeoGenomics (NEO) COO receives new stock option and RSU grants - Stock Titan

Mar 03, 2026

Mar 03, 2026

Major equity grants to NeoGenomics (NEO) CEO Anthony P. Zook - Stock Titan

Mar 03, 2026

Mar 03, 2026

NeoGenomics at TD Cowen Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mar 03, 2026

Mar 03, 2026

NeoGenomics at TD Cowen Conference: Strategic Growth Insights - Investing.com South Africa

Mar 03, 2026

Mar 03, 2026

A Look At NeoGenomics (NEO) Valuation After The RaDaR ST Assay Launch - simplywall.st

Mar 03, 2026

Mar 03, 2026

NeoGenomics Stock Price Drops Below 200-Day Average - National Today

Mar 03, 2026

Mar 03, 2026

NeoGenomics (NASDAQ:NEO) Stock Price Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat

Mar 03, 2026

Mar 02, 2026

NeoGenomics (NEO) CFO Abhishek Jain granted options and RSUs - Stock Titan

Mar 02, 2026

Mar 02, 2026

Oversold Conditions For NeoGenomics (NEO) - Nasdaq

Mar 02, 2026

Mar 02, 2026

NEO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026

Mar 01, 2026

NEO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 01, 2026

Feb 27, 2026

Earnings are out: How did SWFL companies perform? - Naples Daily News

Feb 27, 2026

Feb 26, 2026

Natera, NeoGenomics Unit End Patent Suit Over Lung Cancer Test - Bloomberg Law News

Feb 26, 2026

Feb 26, 2026

3 Reasons to Avoid NEO and 1 Stock to Buy Instead - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

(NEO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Feb 26, 2026

Feb 25, 2026

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tu - PharmiWeb.com

Feb 25, 2026

Feb 25, 2026

NeoGenomics Launches RaDaR ST Molecular Residual Disease Test - marketscreener.com

Feb 25, 2026

Feb 25, 2026

NeoGenomics, Inc. Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - marketscreener.com

Feb 25, 2026

Feb 25, 2026

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - The Joplin Globe

Feb 25, 2026

Feb 24, 2026

NeoGenomics, Inc. Trade Ideas — FWB:NG9 - TradingView

Feb 24, 2026

Feb 24, 2026

NeoGenomics outlines $793M–$801M 2026 revenue target as RaDaR ST and PanTracer initiatives gain traction - MSN

Feb 24, 2026

Feb 24, 2026

NeoGenomics (NEO) COO logs RSU vesting and tax share withholding - Stock Titan

Feb 24, 2026

Feb 24, 2026

Equity moves for NeoGenomics (NASDAQ: NEO) CFO Jeffrey Sherman - Stock Titan

Feb 24, 2026

Feb 24, 2026

NeoGenomics (NEO) EVP nets new shares from RSU vesting and tax withholding - Stock Titan

Feb 24, 2026

Feb 24, 2026

NeoGenomics (NEO) CAO converts RSUs to stock and withholds shares for taxes - Stock Titan

Feb 24, 2026

Feb 24, 2026

NeoGenomics, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Indicators - Markets Mojo

Feb 24, 2026

Feb 24, 2026

5 Insightful Analyst Questions From NeoGenomics's Q4 Earnings Call - Finviz

Feb 24, 2026

Feb 24, 2026

NeoGenomics, Inc. (NEO) Stock Analysis: A 47% Upside Potential in the Healthcare Diagnostics Sector - DirectorsTalk Interviews

Feb 24, 2026

Feb 24, 2026

5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call - Yahoo Finance

Feb 24, 2026

Feb 23, 2026

NeoGenomics (NEO) Q4 2025 Earnings Call Transcript - AOL.com

Feb 23, 2026

Feb 23, 2026

NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Feb 23, 2026

Feb 22, 2026

Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - Yahoo Finance

Feb 22, 2026

Feb 21, 2026

NeoGenomics, Inc. $NEO Shares Bought by White Pine Capital LLC - MarketBeat

Feb 21, 2026

Feb 21, 2026

NeoGenomics, Inc. $NEO Stock Holdings Lifted by Aberdeen Group plc - MarketBeat

Feb 21, 2026

Feb 20, 2026

Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Feb 20, 2026

Feb 20, 2026

After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for NeoGenomics (NEO) - Finviz

Feb 20, 2026

Feb 19, 2026

NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference - ACCESS Newswire

Feb 19, 2026

Feb 19, 2026

Why is NeoGenomics Inc. stock going upM&A Rumor & Free High Accuracy Swing Entry Alerts - mfd.ru

Feb 19, 2026

Feb 19, 2026

UBS Maintains Hold on NeoGenomics, Inc. (NEO) on Feb 18, 2026 - Meyka

Feb 19, 2026

Feb 19, 2026

Needham & Company LLC Forecasts Strong Price Appreciation for NeoGenomics (NASDAQ:NEO) Stock - Defense World

Feb 19, 2026

Feb 19, 2026

NeoGenomics Q4 Earnings Call Highlights - Defense World

Feb 19, 2026

Feb 19, 2026

NeoGenomics Faces High-Stakes Risk as Test Reliability and Diagnostic Errors Threaten Reputation and Legal Exposure - TipRanks

Feb 19, 2026